$ARBK Balance Sheet | Understand Stock

$ARBK

$1.60 +$0.00 (0.01%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Non-current assets
Investment in subsidiaries
Separate
Total investment in subsidiaries

Investments at fair value through income or loss
Investments accounted for using the equity method
Intangible fixed assets, net of accumulated amortization and impairment of £3,888,000 and £571,000 for December 31, 2022 and 2021 respectively
Intangible fixed assets
Property, plant and equipment
Right of use assets
Total non-current assets

Current assets
Trade and other receivables
Prepaids
Intangible fixed assets
Cash and cash equivalents
Total current assets other than assets held for sale
Assets held for sale
Total current assets
Total Assets
EQUITY AND LIABILITIES
Equity
Common stock, 0.001 par value
Common Stock
Additional paid-in capital
Share based payment reserve
Currency translation reserve
Fair value reserve
Other comprehensive income of equity accounted associates
Accumulated surplus (loss)
Total equity

Current liabilities
Trade and other payables
Income Tax
Deferred Tax
Contingent consideration
Loans and Borrowings
Lease liability
Current liabilities
Liabilities held for sale
Total current liabilities

Non-current liabilities
Deferred tax
Issued debt - bond
Loans
Lease liability
Loans and borrowing

Total liabilities
Total equity and liabilities

Comments